TSOI 0037. Lawmakers and conservative advocates wh
Post# of 12921
![](/assets/46931549/no_avatar_available_thumb.jpg)
The “free to choose” idea is in early stages of conversation, largely among conservatives. It would shortcut clinical trials, which are the costliest of the decade-long drug development process and can run into the billions.
The free-to-choose push seeks to build upon the Right to Try Act, which President Donald Trump signed into law last year. It allows patients with life-threatening diseases to petition a drug company for an...
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)